| Literature DB >> 30416940 |
Awais Anwar1,2, Emma Gould2, Ryan Tinson2, Javaid Iqbal3, Chris Hamilton2.
Abstract
PURPOSE OF REVIEW: This article provides a brief overview of natural phytoprotective products of allium with a special focus on the therapeutic potential of diallyl polysulfanes from garlic, their molecular targets and their fate in the living organisms. A comprehensive overview of antimicrobial and anticancer properties of published literature is presented for the reader to understand the effective concentrations of polysulfanes and their sensitivity towards different human pathogenic microbes, fungi, and cancer cell lines. RECENTEntities:
Keywords: Allium sativum; Chemo-prevention; Garlic; Glutathione; Polysulfanes; Reactive sulfur species; Redox modulators
Year: 2018 PMID: 30416940 PMCID: PMC6208768 DOI: 10.1007/s40495-018-0153-2
Source DB: PubMed Journal: Curr Pharmacol Rep ISSN: 2198-641X
Fig. 1A selection of the redox-sulfur chemistry found in garlic. Garlic produces various other chemicals which are not part of this review. The polysulfanes produced by garlic on crushing vastly depend on methods of extraction and temperature [5]. In figure DAS1 (diallyl sulfane), DAS2 (diallyl disulfane), DAS3 (diallyl trisulfane), DAS4 (diallyl tetrasulfane), DAS5 (diallyl pentasulfane)
MIC values (mg/L) of polysulfanes against different human pathogenic bacteria. MIC values have been converted to mg/L where other concentration units were reported in the literature
| Garlic component/preparation | Organism | MIC (mg/L) | Reference |
|---|---|---|---|
| Allicin |
| 6–12 | [ |
| 64 | [ | ||
| 64 | |||
| 64 | |||
|
| 64 | ||
|
| 32 | ||
|
| 32 | ||
|
| 32 | ||
|
| 16 | ||
|
| 23 | [ | |
| DAS1 |
| 2074–4148 | [ |
|
| 64 | [ | |
|
| 56 | ||
|
| 64 | ||
|
| 72 | ||
|
| 48 | ||
|
| 54 | ||
|
| 64 | ||
|
| 72 | ||
| DAS2 |
| 2 | [ |
|
| 100 | ||
|
| 14 | [ | |
|
| 12 | ||
|
| 20 | ||
|
| 20 | ||
|
| 8 | ||
|
| 12 | ||
|
| 16 | ||
|
| 24 | ||
| DAS3 |
| 0.5 | [ |
|
| 13–25 | ||
|
| 4 | [ | |
|
| 2 | ||
|
| 4 | ||
|
| 12 | ||
|
| 2 | ||
|
| 2 | ||
|
| 8 | ||
|
| 12 | ||
|
| 2.5 | [ | |
| DAS4 |
| 3–6 | [ |
|
| 1 | [ | |
|
| 1 | ||
|
| 1 | ||
|
| 4 | ||
|
| 0.5 | ||
|
| 0.5 | ||
|
| 2 | ||
|
| 4 | ||
| Garlic oila |
| 8–32 | [ |
|
| 40 | [ | |
|
| 36 | ||
|
| 32 | ||
|
| 48 | ||
|
| 20 | ||
|
| 32 | ||
|
| 36 | ||
|
| 40 | ||
|
| 2.75 | [ | |
|
| 2.75 | ||
|
| 2.75–5.5 | ||
|
| 0.34 | ||
|
| 0.08 | ||
|
| 0.68 | ||
|
| 0.49 | ||
|
| 0.49 | ||
|
| 0.04 | ||
|
| 0.17–0.68 | ||
|
| 0.68 | ||
|
| 0.34 | ||
|
| 0.17 | ||
|
| 2.74 | ||
|
| 0.34–2.75 | ||
|
| 0.34 | ||
|
| 0.08 | ||
|
| 0.04 | ||
| Garlic extracta |
| 16.6 | [ |
|
| 6 | ||
|
| 62.5 | ||
|
| 4 | [ | |
|
| 7 | ||
|
| 0.1 | [ | |
|
| 0.2 | ||
|
| 0.9 | ||
|
| 0.02 | ||
| 7–21 | [ | ||
|
| 2–5 | [ | |
|
| 22.9 | [ | |
|
| 30.3 | ||
|
| 33 | ||
|
| 30.5 | ||
| 15.6 | |||
|
| 3.5 | ||
|
| 4–32 | [ |
aActivity depends on how garlic oil and garlic extract are manufactured. Various papers depicting the biological activity of polysulfanes did not mention the characterization of such preparations. The concentrations of individual polysulfanes in an extract or oil widely depend on method of extraction or distillation
MIC (mg/L) of polysulfanes against different pathogenic fungal species. MIC values have been converted to mg/L where other concentration units were reported in the literature
| Garlic component/preparation | Organism | MIC (mg/L) | Percentage inhibition at MIC (%) | Reference |
|---|---|---|---|---|
| Allicin |
| 0.8 | 100 | [ |
|
| 0.3 | |||
|
| 0.15 | |||
|
| 0.3 | |||
|
| 0.3 | |||
|
| 0.3 | |||
| 8–32 | 100 | [ | ||
|
| 12.5 | 90 | [ | |
| DAS2 |
| 8 | 100 | [ |
|
| 1 | |||
|
| 8 | |||
|
| 4 | |||
|
| 2 | |||
|
| 8 | |||
|
| 4 | |||
| DAS3 |
| 2 | 100 | [ |
|
| 0.5 | |||
|
| 4 | |||
|
| 2 | |||
|
| 1 | |||
|
| 4 | |||
|
| 2 | |||
| Garlic oila |
| 0.35 | 100 | [ |
|
| 0.69 | |||
| Garlic extracta | 14.9 | 100 | [ |
aActivity depends on how garlic oil and garlic extract are manufactured. Various papers depicting the biological activity of polysulfanes did not mention the characterization of such preparations. The concentrations of polysulfanes in an extract or oil widely depend on method of extraction or distillation
Effect of polysulfanes on different human cancer cell lines and their molecular targets. The concentration units reported in the literature have all been converted to mg/mL so they can be compared with the antimicrobial activities in Tables 1 and 2
| Redox modulator | Cancer type/cell line | Dose (mg/mL) | Target | Effect | Reference |
|---|---|---|---|---|---|
| Ajoene | Leukemia | 9.36 | Bcl-2 | Inhibition of proliferation and induction of apoptosis | [ |
| HL-60, U937, HEL and OCIM-1 | Caspase-3 | ||||
| DAS2 | Breast cancer | 2.6 | Estrogen receptor (ER)-positive (KPL-1 and MCF-7) and -negative (MDA-MB-231 and MKL-F) | Growth inhibition of cancer cells by inducing apoptosis | [ |
| MDA-MB-231 | |||||
| DAS2 | Breast | 29.2 | Kinase protein | Inhibited proliferation of MCF-7 cells and increased apoptotic ratio | [ |
| MCF-7 | |||||
| Caspase-3 | |||||
| DAS2 | Colon | 29.2 | Histone H3 and H4 | Inhibition of caner proliferation by interaction with HDAC pathway | [ |
| Caco-2, HT-29 | |||||
| DAS3 | Liver | 35 | Caspase-3 | Increased H2O2 levels, lowered thiol levels and inhibited cell proliferation | [ |
| HepG2 | |||||
| DAS3 | Colon | 2.0 | Tubulin | Suppression of cell growth | [ |
| HCT-15 | 2.3 | ||||
| DLD-1 | |||||
| DAS3 | Prostate | 7.1 | CDK1 | Inhibition of cells by dose dependent manner. | [ |
| PC-3 | |||||
| DAS3 | Gastric | 20.5 | Bcl-2 | Inhibited viability of BCG-823 in vitro and modulated Bcl-2. | [ |
| BGC-823 | |||||
| DAS3 | Breast | 1.78 | MMP2/9 | Suppressed metastasis | [ |
| MDA-MB-231 | |||||
| HS 578t | |||||
| DAS3 | Colon | 8.91 | Focal adhesion kinase (FAK | Inhibition of angiogenesis | [ |
| HT29 | |||||
| DAS3 | A375 | 17.8 | Mitochondrial caspase pathway | Increase in ROS | [ |
| Skin | |||||
| DAS3 | Lymphoma | 3.56 | NF-κB | Apoptosis in primary effusion lymphoma [PEL] | [ |
| BC2, BC3, | |||||
| BCBL1, HBL6 | |||||
| DAS3 | Prostate | 3.56 | Androgen receptor (AR) | Decrease in AR levels | [ |
| LNCaP, C4-2, TRAMP-C1 | |||||
| DAS3 | Glioblastoma | 17.8 | Bcl-2 | Inhibition and proliferation | [ |
| U87MG | |||||
| Neuroblastoma | |||||
| SH-SY5Y |
Fig. 2A summary of diallyl polysulfane reactions/interactions in vivo and their physiological consequences [1]. Once polysulfanes enter the target cell, they can react with thiols (GSH) to produce hydropolysulfane (RSxH), which upon oxidation (ROS) can produce perthiyl radicals (RSS•). Perthiyl radicals can decompose into thiyl radicals (RS•), after accepting an electron they can result in formation of thiols. The pathways of such species have been discussed previously, and hence, will not be presented here [2, 4]. Diallyl polysulfanes can either enhance or suppress cytochrome P450s, which are involved in the detoxification process [59]. It is hypothesized that reduction of polysulfanes leads to the production of allyl mercaptan (AM) which can be further methylated by S-adenosyl methionine synthetase into allyl methyl sulfide (AMS) [60, 61]. AM and AMS have been determined as DAS1 and DAS2 metabolites [62]. SAM S-adenosyl methionine, SAH S-adenosyl homocysteine